eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
his heart, beating for 84 years and full of love for the woman he affectionately called his "blue-eyed guera [pronounced whedda]," felt like it was failing.
.
bruschi, who said he never fell into smoking cigarettes though he enjoys a cigar now and then, has a favorable view of raising the tobacco purchase age, too.
.
.